ePrints

Frailty scores and their utility in older patients with cardiovascular disease

Lookup NU author(s): Dr Chris WilkinsonORCiD, Dr Murugu Veerasamy, Professor Vijay KunadianORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Abstract

© 2021 Radcliffe Group Ltd. All rights reserved.The world's population is ageing, resulting in more people with frailty receiving treatment for cardiovascular disease (CVD). The emergence of novel interventions, such as transcatheter aortic valve implantation, has also increased the proportion of older patients being treated in later stages of life. This increasing population burden makes the assessment of frailty of utmost importance, especially in patients with CVD. Despite a growing body of evidence on the association between frailty and CVD, there is no consensus on the optimal frailty assessment tool for use in clinical settings. Previous studies have shown limited concordance between validated frailty instruments. This review evaluates the evidence on the utility of frailty assessment tools in patients with CVD, and the effect of frailty on different outcomes measured.

Publication metadata

Author(s): Chung KJNC, Wilkinson C, Veerasamy M, Kunadian V

Publication type: Article

Publication status: Published

Journal: Interventional Cardiology Review

Year: 2021

Volume: 16

Online publication date: 31/03/2021

Acceptance date: 09/12/2020

Date deposited: 10/05/2021

ISSN (print): 1756-1477

ISSN (electronic): 1756-1485

Publisher: Radcliffe Cardiology

URL: https://doi.org/10.15420/ICR.2020.18

DOI: 10.15420/ICR.2020.18

Altmetrics

Share